Table 1.
Location of purchase | Approval status
|
||
---|---|---|---|
Total | Failed | % fail | |
SRA | |||
African cities | 239 | 4 | 1.67% |
Indian cities | 14 | 0 | 0.00% |
Cities of other studied countriesa | 142 | 0 | 0.00% |
Total | 395 | 4 | 1.01% |
WHO | |||
African cities | 191 | 18 | 9.42% |
Indian cities | 210 | 10 | 4.76% |
Cities of other studied countriesa | 11 | 0 | 0.00% |
Total | 412 | 28 | 6.80% |
Neither SRA or WHO | |||
African cities | 935 | 172 | 18.40% |
Indian cities | 619 | 56 | 9.05% |
Cities of other studied countriesa | 291 | 12 | 4.12% |
Total | 1845 | 240 | 13.01% |
Total | |||
African cities | 1365 | 194 | 14.21% |
Indian cities | 843 | 66 | 7.83% |
Cities of other studied countriesa | 444 | 12 | 2.70% |
Total | 2652 | 272 | 10.26% |
Note:
Countries include Thailand, China, Turkey, Russia, and Brazil.
Abbreviations: SRA, stringent regulatory authority; WHO, World Health Organization.